CD8A and neoplasm: Since tumor-induced T cell anergy is an important barrier that limits the generation of potent anti-tumor immunity [29], we sought to determine whether OX40 ligation in the presence of TCR/IL-2c signaling would restore the function of anergic CD8 T cells in tumor-bearing hosts.